News

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...
Even before the FDA's authorization of Moderna and J&J boosters, CDC data show that more than 1.6 million people have received a Moderna booster and more than 11,000 another shot of J&J's ...
As a scientist with the FDA explained, a Moderna study of about 170 people who received a booster shot missed its goal of increasing immune activity fourfold against COVID-19.
The FDA advisory panel also will consider mixing and matching vaccines. An independent Food and Drug Administration advisory panel on Thursday voted unanimously to authorize Moderna Covid-19 ...
The FDA’s panel of pediatric and immunology experts reviewed two studies conducted by Moderna in children, which showed that kids ages six to 17 generated levels of virus-neutralizing antibodies ...
The Food and Drug Administration's vaccine advisory committee met Thursday to consider whether a Moderna booster shot is safe and helpful in the country's fight against COVID-19. Today, the FDA's ...
The FDA’s vaccine advisers will evaluate next week Moderna’s Covid-19 vaccines for children 6 months through 5 years and 6 years through 17 years should be granted emergency use authorization.
FDA scientists and experts said there was strong evidence the Moderna vaccine is 94.5% effective at preventing COVID-19 cases at least 14 days after vaccination and that there were no significant ...
FDA review finds Moderna’s booster dose of its coronavirus vaccine strengthens disease-fighting response Updated October 12, 2021 More than 3 years ago Summary ...
The FDA didn’t find any significant safety issues with the Moderna vaccine, aside from common side effects such as fatigue and muscle aches.